12.16.25 -- STREAM Edition: Building A Cancer Pipeline In A Molecule

In this workshop, you’ll learn about various solutions, from cell isolation to cell expansion, that can support autologous and allogeneic cell therapy process needs, digital automation, and mycoplasma testing.

 

Learn about an Innovation Hub that specializes in freezing studies to provide insight into the performance of single-use cryopreservation solutions for manufacturing and delivering advanced therapies.

This elutriation and wash system can be used to initiate a wide number of cell therapy manufacturing processes such as CAR-T, dendritic cells, TIL, and IPSC-derived therapy.

The streamlined AAV transient transfection platform de-risks your path to IND and reduces complexity and timeline for lengthy process and analytical development.

Meet a cell therapy manufacturing platform, an end-to-end solution that digitally integrates two systems via innovative software, giving you the confidence you need to deliver your therapy.

Unlike conventional predictive biomarkers, which often focus on isolated molecular markers, this strategy integrates spatial metabolomics and genomics, providing a multidimensional perspective.

On this week's episode of the Business of Biotech, Dan Schmitt, President and CEO at Actuate Therapeutics, talks about building a company around elraglusib, a GSK-3Β inhibitor for cancer.